Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2 (PrEliMS2)
Multiple Sclerosis

About this trial
This is an interventional treatment trial for Multiple Sclerosis focused on measuring Acceptance and Commitment Therapy
Eligibility Criteria
Inclusion Criteria:
- Aged 18 and/or over.
- Received a new diagnosis of MS within the last six months, confirmed by a Consultant Neurologist.
- Scores ≥8 on the GAD-7 and/or ≥10 on the PHQ-9.
Exclusion Criteria:
- Unable or willing to give informed consent.
- Individuals currently receiving psychological therapy, to ensure any change cannot be attributed to another intervention.
- Individuals who have had a prior diagnosis of psychological distress, e.g., Depression or Anxiety Disorder, to ensure participants are as homogenous as possible. The intervention is aimed at distress specifically related to receiving an MS diagnosis.
- Unable to speak and read English (as all measure used have been standardised and validated in English, and the workbook is only available in English).
- Unable to use/do not have access to a telephone or a computer with internet connection
Sites / Locations
- Queens Medical Hospital
Arms of the Study
Arm 1
Experimental
PrEliMS Intervention
We will ask participants to complete the anxiety/depression questionnaires and visual analogue scales once a week throughout the participants involvement in the study (estimated to be 9 weeks). The baseline will be established over a period of the first three weeks (before participants start the intervention). Participants will also be asked to complete a second set of questionnaires (secondary measures) before starting the intervention, to assess quality of life, stress, the impact of MS, MS-related self-efficacy and fatigue. The procedure will then repeated with newly recruited participants, and the newly refined workbook will be used. Participants within this phase will also be invited to feedback interviews a week after completion of the intervention.